LC-MS-Based Serum Metabolomic Analysis Predicts the Risk of Tigecycline-Induced Coagulopathy in Critically Ill Patients
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s539874 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Na Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Nanjing Drum Tower Hospital, Nanjing Drum Tower Hospital Clinical College, Nanjing University of Chinese Medicine, Nanjing, P…. Hauptthemen laut MEDLINE: Tigecycline, Metabolomics, Anti-Bacterial Agents, Blood Coagulation Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Nanjing Drum Tower Hospital, Nanjing Drum Tower Hospital Clinical College, Nanjing University of Chinese Medicine, Nanjing, People's Republic of China.
- Department of Pharmacy, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, People's Republic of China.
- Department of Pharmacy, Hospital of Zhejiang People's Armed Police (PAP), Hangzhou, People's Republic of China.
Zitieren
APA
Yang, N., Zheng, X., Ji, X., Yao, H., Xu, K., Zhang, T., Jin, L., Zhu, H., & Wang, M. (2025). LC-MS-Based Serum Metabolomic Analysis Predicts the Risk of Tigecycline-Induced Coagulopathy in Critically Ill Patients. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s539874
Vancouver
Yang N, Zheng X, Ji X, Yao H, Xu K, Zhang T, et al. LC-MS-Based Serum Metabolomic Analysis Predicts the Risk of Tigecycline-Induced Coagulopathy in Critically Ill Patients. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s539874
BibTeX
@article{Yang2025,
author = {Yang, Na and Zheng, Xinxin and Ji, Xinyue and Yao, Hui and Xu, Ke and Zhang, Tianqi and Jin, Lu and Zhu, Huaijun and Wang, Min},
title = {LC-MS-Based Serum Metabolomic Analysis Predicts the Risk of Tigecycline-Induced Coagulopathy in Critically Ill Patients},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s539874}
}
EUVIMED